Rivaroxaban

NDC 59651-849 · Aurobindo Pharma Limited

Generic nameRivaroxaban

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)RIVAROXABAN

Strength2.5 mg/1

Pharmacologic classFactor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]

Marketing categoryANDA

Packages

59651-849-18 — 180 TABLET, FILM COATED in 1 BOTTLE (59651-849-18)

59651-849-60 — 60 TABLET, FILM COATED in 1 BOTTLE (59651-849-60)

FDA lists these products with the same active ingredient.

50458-578 — rivaroxaban, 50458-579 — rivaroxaban, 50458-580 — rivaroxaban, 51672-4228 — Rivaroxaban, 55154-1422 — rivaroxaban, 55154-1423 — rivaroxaban, 55154-1424 — rivaroxaban, 55488-0540 — rivaroxaban, 55488-0541 — rivaroxaban, 55488-0542 — rivaroxaban, 60505-6256 — Rivaroxaban, 62332-346 — RIVAROXABAN, 62332-347 — RIVAROXABAN, 62332-348 — RIVAROXABAN, 62332-683 — RIVAROXABAN, 67877-882 — Rivaroxaban, 68180-709 — RIVAROXABAN, 70748-355 — rivaroxaban granule, 71610-690 — rivaroxaban, 71921-405 — rivaroxaban, +23 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.